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A minority of symptoms of CCHF 
Ixodes scapularis (Black legged Ticks) before blood 
indulgence 
Introduction 
The Crimean-Congo Hemorrhagic Fever (CCHF) is a tick-
borne infectious viral disease in the family Bunyaviridae. The 
disease was first characterized in the Crimea in 1944 and given 
the name Crimean hemorrhagic fever. CCHF was then later 
recognized in 1969 as the cause of illness in the Congo, thus 
resulting in the current name of the disease. CCHF causes 
severe viral hemorrhagic fever outbreaks (CDC, 2014). 
 
Location 
Crimean-Congo hemorrhagic fever is found in Eastern Europe, 
particularly in the former Soviet Union, throughout the 
Mediterranean, in northwestern China, central Asia, southern 
Europe, Africa, the Middle East, and the Indian subcontinent 
(CDC, n.d.). 
  
 
 
 
 
 
 
 
 
 
 
 
Transmission 
The CCHF virus is transmitted to people either by tick bites or 
through contact with infected animal blood or tissues during 
and immediately after slaughter.   Human-to-human 
transmissions occurred with contact with secretion, blood, 
organs, or any other bodily fluids of an infected body. Hospital-
acquired infections can also occur due to improper sterilization 
of medical equipment, reuse of needles and contamination of 
medical supplies (WHO, n.d.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protection 
Protection of exposed skin around other infected animals 
or other humans are the only option. Insect repellant is 
may be used for the protection against of CCHF. 
Individuals should also avoid close contact with the 
blood and body fluids of livestock or humans who show 
symptoms of infection. An inactivated, mouse-brain 
derived vaccine against CCHF has been developed and is 
used on a small scale in Eastern Europe. However, there 
is no safe and effective vaccine currently available for 
human use (CDC, 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
Symptoms 
The onset of CCHF is sudden, with initial signs and symptoms 
including headache, high fever, back pain, dizziness, neck pain 
and/or stiffness, sore eyes, photophobia (sensitivity of light), joint 
pain, stomach pain, and vomiting. Red eyes, a flushed face, a red 
throat, and petechiae (red spots) on the palate are common. 
Symptoms may also include jaundice (yellow color of the skin, 
mucus membranes, or eyes), and in severe cases, changes in mood 
and sensory perception (NCBI, n.d.).  
 
As the illness progresses, large areas of severe bruising, severe 
nosebleeds, and uncontrolled bleeding at injection sites can be seen, 
with fatality rates in hospitalized patients have ranged from 9% to as 
high as 50% (NCBI, n.d.). 
  
Treatment 
Being bitten by ticks, 61.3% stated they could recognize ticks and 
56.1% stated that not all tick bites cause the disease. Seventy-seven 
point eight percent stated CCHF is a virulent disease, 33.1% stated it 
can be transmitted from human to human and 30.3% stated it can be 
transmitted from animals to humans. (NCBI, February 11, 2015).  
Because CCHF is a virus of the Bunyaviridae family or of any other 
virus, there is no absolute cure but instead just intensive supportive 
care. The antiviral drug called ribavirin has been used in the 
treatment of CCHF patients reportedly with some benefit (WHO, 
n.d.) 
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